Development of Bivalent (B/E) Vaccines Able to Neutralize CCR5-Dependent Viruses from the United States and Thailand
- 1 December 1999
- Vol. 265 (1) , 1-9
- https://doi.org/10.1006/viro.1999.0031
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Genetic and Immunologic Characterization of Viruses Infecting MN‐rgp120‐Vaccinated VolunteersThe Journal of Infectious Diseases, 1997
- The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 IsolatesPublished by Elsevier ,1996
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5Nature, 1996
- Identification of a major co-receptor for primary isolates of HIV-1Nature, 1996
- Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1995
- Neutralizing Antibodies to HIV-1 in Seronegative Volunteers Immunized With Recombinant gp 120 From the MN Strain of HIV-1JAMA, 1994
- Adhesion Mediated by Intercellular Adhesion Molecule 1 Attenuates the Potency of Antibodies That Block HIV-1 gp160-Dependent Syncytium FormationAIDS Research and Human Retroviruses, 1994
- Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity.Proceedings of the National Academy of Sciences, 1991
- High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.Proceedings of the National Academy of Sciences, 1990